

					
						November 10, 2017 - By Vivian Park
The stock of TapImmune Inc (NASDAQ:TPIV) hit a new 52-week low and has $2.52 target or 6.00% below today’s $2.68 share price. The 6 months bearish chart indicates high risk for the $27.22M company. The 1-year low was reported on Nov, 10 by Barchart.com. If the $2.52 price target is reached, the company will be worth $1.63 million less. About 5,557 shares traded. TapImmune Inc (NASDAQ:TPIV) has declined 49.91% since November 10, 2016 and is downtrending. It has underperformed by 66.61% the S&P500.Manning & Napier Advisors Llc decreased Ambev Sa (ABEV) stake by 3.03% reported in 2017Q2 SEC filing. Manning & Napier Advisors Llc sold 1.96 million shares as Ambev Sa (ABEV)’s stock declined 1.05%. The Manning & Napier Advisors Llc holds 62.78 million shares with $344.69 million value, down from 64.74 million last quarter. Ambev Sa now has $96.98B valuation. The stock declined 1.62% or $0.1 reaching $6.08 per share. About 9.42M shares traded. Ambev SA (ADR) (NYSE:ABEV) has risen 10.52% since November 10, 2016 and is uptrending. It has underperformed by 6.18% the S&P500.TapImmune Inc. is an immuno-oncology company. The company has market cap of $27.22 million. The Firm specializes in the development of peptide and gene immunotherapeutics and vaccines for the treatment of cancer. It currently has negative earnings. The Firm is engaged in developing vaccines that target candidate breast cancers, colorectal cancers, ovarian cancers and non-small cell lung cancers.Among 6 analysts covering AmBev SA (NYSE:ABEV), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. AmBev SA had 9 analyst reports since September 17, 2015 according to SRatingsIntel. The stock has “Equal-Weight” rating by Barclays Capital on Friday, October 27. The firm earned “Equal-Weight” rating on Thursday, August 18 by Morgan Stanley. The stock of Ambev SA (ADR) (NYSE:ABEV) earned “Hold” rating by Barclays Capital on Friday, July 28. The company was upgraded on Tuesday, September 12 by Credit Suisse. The firm has “Buy” rating given on Monday, October 10 by Goldman Sachs. JP Morgan upgraded Ambev SA (ADR) (NYSE:ABEV) on Thursday, November 10 to “Overweight” rating. Barclays Capital reinitiated Ambev SA (ADR) (NYSE:ABEV) rating on Thursday, November 3. Barclays Capital has “Equal Weight” rating and $6 target.Manning & Napier Advisors Llc increased Sysco Corp (NYSE:SYY) stake by 35,954 shares to 124,660 valued at $6.27M in 2017Q2. It also upped Sba Communications Corp New stake by 6,898 shares and now owns 333,773 shares. Home Depot Inc (NYSE:HD) was raised too. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.